These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 944527)

  • 1. Anti-drug-related antibodies in nonthrombocytopenic cardiac patients.
    Okuno T; Crockatt D
    Am J Clin Pathol; 1976 Apr; 65(4):523-7. PubMed ID: 944527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on quinine- and quinidine-dependent antibodies against platelets and their reaction with platelets in the Bernard-Soulier syndrome.
    van Leeuwen EF; Engelfriet CP; von dem Borne AE
    Br J Haematol; 1982 Aug; 51(4):551-60. PubMed ID: 7049220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 125 I-anti-immunoglobulin test: a new tool for the detection of drug-allergic platelet antibodies.
    Mueller-Eckhardt C; Schulz G; Dienst C; Mahn I; Mayser B
    Vox Sang; 1978; 34(1):43-5. PubMed ID: 341521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-platelet antibody determination by platelet factor 3 assay.
    Okuno T; Crockatt D
    Am J Clin Pathol; 1976 Sep; 66(3):475-8. PubMed ID: 961626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quinidine-induced thrombocytopenic purpura: clinical presentation in relation to drug-dependent and drug-independent platelet antibodies.
    Nieminen U; Kekomäki R
    Br J Haematol; 1992 Jan; 80(1):77-82. PubMed ID: 1536813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of drug-dependent antibodies by the 51Cr platelet lysis test: documentation of immune thrombocytopenia induced by diphenylhydantoin, diazepam, and sulfisoxazole.
    Cimo PL; Pisciotta AV; Desai RG; Pino JL; Aster RH
    Am J Hematol; 1977; 2(1):65-72. PubMed ID: 868869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug purpura due to surreptitious quinidine intake.
    Reid DM; Shulman NR
    Ann Intern Med; 1988 Feb; 108(2):206-8. PubMed ID: 3341652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoreactions involving platelets. III. Quantitative aspects of platelet agglutination, inhibition of clot retraction, and other reactions caused by the antibody of quinidine purpura.
    SHULMAN NR
    J Exp Med; 1958 May; 107(5):697-710. PubMed ID: 13525580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CHANGE IN PLATELET FACTOR 3 AS A MEANS OF DEMONSTRATING IMMUNE REACTIONS INVOLVING PLATELETS: ITS USE AS A TEST FOR QUINIDINE-INDUCED THROMBOCYTOPENIA.
    HOROWITZ HI; RAPPAPORT HI; YOUNG RC; FUJIMOTO MM
    Transfusion; 1965; 5():336-43. PubMed ID: 14316534
    [No Abstract]   [Full Text] [Related]  

  • 10. Structural features of the quinidine and quinine molecules necessary for binding of drug-induced antibodies to human platelets.
    Christie DJ; Weber RW; Mullen PC; Cook JM; Aster RH
    J Lab Clin Med; 1984 Nov; 104(5):730-40. PubMed ID: 6491470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiplatelet antibody determination using platelet factor 3 assay in thrombocytopenic patients.
    Chong LL
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1986 Nov; 19(4):233-7. PubMed ID: 3816366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of quinidine-specific antibodies with platelet 125I-labeled staphylococcal protein A test.
    Kekomäki R; Rajamäki A; Myllylä G
    Vox Sang; 1980; 38(1):12-8. PubMed ID: 7376562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The assessment of drug-dependent and isoimmune antiplatelet antibodies by the use of platelet aggregometry.
    Deykin D; Hellerstein LJ
    J Clin Invest; 1972 Dec; 51(12):3142-53. PubMed ID: 4674399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differing susceptibilities of platelets from normal individuals and patients with von Willebrand's disease to attack by quinine- and quinidine-dependent antiplatelet antibodies.
    Pfueller SL; Bilston RA; Logan D; David R; Sloan IG; Firkin BG
    Thromb Haemost; 1989 Feb; 61(1):111-6. PubMed ID: 2787540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet migration inhibition: a new method for detection of platelet antibodies.
    Duquesnoy RJ; Lorentsen DF; Aster RH
    Blood; 1975 Jun; 45(6):741-7. PubMed ID: 1168511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The human platelet receptor(s) for quinine/quinidine-dependent antibodies.
    Kunicki TJ; Christie DJ; Aster RH
    Blood Cells; 1983; 9(2):293-301. PubMed ID: 6318869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoreactions involving platelets. IV. Studies on the pathogenesis of thrombocytopenia in drug purpura using test doses of quinidine in sensitized individuals; their implications in idiopathic thrombocytopenic purpura.
    SHULMAN NR
    J Exp Med; 1958 May; 107(5):711-29. PubMed ID: 13525581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune thrombocytopenic purpura.
    Koller CA
    Med Clin North Am; 1980 Jul; 64(4):761-73. PubMed ID: 6995733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet antibodies in non-immunized patients with idiopathic thrombocytopenic purpura (ITP).
    Gandolfo GM; Afeltra A; Ferri GM; Amoroso A; Fidani P; Francesconi M; Mazzucconi MG; Isacchi G
    Haematologica; 1983; 68(1):46-51. PubMed ID: 6404707
    [No Abstract]   [Full Text] [Related]  

  • 20. Study of the factors that cause specific transformation in cultures of lymphocytes from patients with quinine- and quinidine-induced immune thrombocytopenia.
    Hosseinzadeh PK; Firkin BG; Pfueller SL
    J Clin Invest; 1980 Oct; 66(4):638-45. PubMed ID: 6999032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.